Royce & Associates’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,864
| Closed | -$294K | – | 919 |
|
|
2023
Q3 | $294K | Sell |
13,864
-4,532
| -25% | -$118K | ﹤0.01% | 851 |
|
|
2023
Q2 | $611K | Sell |
18,396
-1,163
| -6% | -$42.8K | 0.01% | 812 |
|
|
2023
Q1 | $769K | Buy |
+19,559
| New | +$813K | 0.01% | 802 |
|
|
2020
Q3 | – | Sell |
-71,347
| Closed | -$2.73M | – | 1113 |
|
|
2020
Q2 | $2.73M | Hold |
71,347
| – | – | 0.03% | 602 |
|
|
2020
Q1 | $1.56M | Buy |
71,347
+1
| +0% | +$30 | 0.02% | 650 |
|
|
2019
Q4 | $2.92M | Buy |
71,346
+40,874
| +134% | +$1.67M | 0.03% | 618 |
|
|
2019
Q3 | $1.3M | Buy |
30,472
+22
| +0.1% | +$923 | 0.01% | 770 |
|
|
2019
Q2 | $1.5M | Sell |
30,450
-952
| -3% | -$48.4K | 0.01% | 778 |
|
|
2019
Q1 | $1.5M | Hold |
31,402
| – | – | 0.01% | 803 |
|
|
2018
Q4 | $1.93M | Sell |
31,402
-1,022
| -3% | -$68.9K | 0.02% | 742 |
|
|
2018
Q3 | $2.67M | Hold |
32,424
| – | – | 0.02% | 765 |
|
|
2018
Q2 | $2.54M | Hold |
32,424
| – | – | 0.02% | 773 |
|
|
2018
Q1 | $2.39M | Hold |
32,424
| – | – | 0.02% | 799 |
|
|
2017
Q4 | $2.21M | Sell |
32,424
-1,151
| -3% | -$74.4K | 0.01% | 822 |
|
|
2017
Q3 | $2.06M | Sell |
33,575
-1,525
| -4% | -$93.6K | 0.01% | 829 |
|
|
2017
Q2 | $2.21M | Hold |
35,100
| – | – | 0.01% | 823 |
|
|
2017
Q1 | $1.95M | Hold |
35,100
| – | – | 0.01% | 871 |
|
|
2016
Q4 | $1.68M | Sell |
35,100
-111,692
| -76% | -$6.26M | 0.01% | 858 |
|
|
2016
Q3 | $9.51M | Sell |
146,792
-724,201
| -83% | -$40.7M | 0.06% | 394 |
|
|
2016
Q2 | $40.2M | Sell |
870,993
-362,364
| -29% | -$14.6M | 0.27% | 104 |
|
|
2016
Q1 | $47.2M | Sell |
1,233,357
-139,426
| -10% | -$4.61M | 0.3% | 90 |
|
|
2015
Q4 | $52M | Sell |
1,372,783
-532,488
| -28% | -$19.6M | 0.31% | 78 |
|
|
2015
Q3 | $78.7M | Sell |
1,905,271
-346,450
| -15% | -$14.9M | 0.42% | 49 |
|
|
2015
Q2 | $106M | Sell |
2,251,721
-33,163
| -1% | -$1.79M | 0.45% | 42 |
|
|
2015
Q1 | $138M | Sell |
2,284,884
-2,340,129
| -51% | -$119M | 0.52% | 34 |
|
|
2014
Q4 | $202M | Buy |
4,625,013
+960,586
| +26% | +$42.4M | 0.7% | 14 |
|
|
2014
Q3 | $165M | Buy |
3,664,427
+182,888
| +5% | +$9.73M | 0.56% | 25 |
|
|
2014
Q2 | $257M | Buy |
3,481,539
+1,557,616
| +81% | +$123M | 0.77% | 9 |
|
|
2014
Q1 | $159M | Sell |
1,923,923
-263,285
| -12% | -$23.1M | 0.47% | 39 |
|
|
2013
Q4 | $302M | Sell |
2,187,208
-1,829,697
| -46% | -$215M | 0.87% | 6 |
|
|
2013
Q3 | $385M | Sell |
4,016,905
-2,839,744
| -41% | -$241M | 1.14% | 4 |
|
|
2013
Q2 | $419M | Buy |
+6,856,649
| New | +$381M | 1.29% | 1 |
|
Other funds holding NUS
Royce & Associates's NUS Position: Q4 2023 in Review
Royce & Associates sold out of Nu Skin (NUS) in Q4 2023, closing a stake of 13,864 shares — an estimated $294K sold.
Royce & Associates first reported a position in NUS in Q2 2013 and held it in 32 quarters. The position peaked at $419M in Q2 2013. 212 funds tracked by Wall St. Rank hold NUS as of Q4 2023.
- Royce & Associates reported no remaining Nu Skin position as of Q4 2023 after selling out during the quarter.
- Royce & Associates sold 13,864 Nu Skin shares in Q4 2023, an estimated $294K.
- Royce & Associates first reported a position in Nu Skin in Q2 2013 and held it in 32 quarters.
- Royce & Associates's Nu Skin position peaked at $419M in Q2 2013.
- 212 funds tracked by Wall St. Rank held Nu Skin as of Q4 2023.
Based on Royce & Associates's 13F filing for Q4 2023, filed 12 Feb 2024.